Stereotactic radiotherapy with focal boost for intermediate and high-risk prostate cancer: Initial results of the SPARC trial

Stereotactic radiotherapy with focal boost for intermediate and high-risk prostate cancer: Initial results of the SPARC trial

Introduction: Dose escalation to dominant intraprostatic lesions (DILs) is a novel method to increase the therapeutic ratio in localised prostate cancer. The Stereotactic Prostate Augmented Radiotherapy with Cyberknife (SPARC) trial was designed to determine the feasibility of a focal boost defined...

Full description

Bibliographic Details
Main Authors: Luke Nicholls, Yae-eun Suh, Ewan Chapman, Daniel Henderson, Caroline Jones, Kirsty Morrison, Aslam Sohaib, Helen Taylor, Alison Tree, Nicholas van As
Format: Article
Language:English
Published: Elsevier 2020-11-01
Series:Clinical and Translational Radiation Oncology
Subjects:
Intermediate- and high-risk
Prostate cancer
Radiotherapy
Stereotactic ablative body radiotherapy
Online Access:http://www.sciencedirect.com/science/article/pii/S2405630820300847

Internet

http://www.sciencedirect.com/science/article/pii/S2405630820300847

Similar Items